Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Mechanistic target of rapamycin complex 1 and 2 in human temporal lobe epilepsy.

Talos DM, Jacobs LM, Gourmaud S, Coto CA, Sun H, Lim KC, Lucas TH, Davis KA, Martinez-Lage M, Jensen FE.

Ann Neurol. 2018 Feb;83(2):311-327. doi: 10.1002/ana.25149. Epub 2018 Feb 15.

2.

Subunit composition of glutamate and gamma-aminobutyric acid receptors in status epilepticus.

Loddenkemper T, Talos DM, Cleary RT, Joseph A, Sánchez Fernández I, Alexopoulos A, Kotagal P, Najm I, Jensen FE.

Epilepsy Res. 2014 May;108(4):605-15. doi: 10.1016/j.eplepsyres.2014.01.015. Epub 2014 Feb 2.

3.

Neuronal Tsc1/2 complex controls autophagy through AMPK-dependent regulation of ULK1.

Di Nardo A, Wertz MH, Kwiatkowski E, Tsai PT, Leech JD, Greene-Colozzi E, Goto J, Dilsiz P, Talos DM, Clish CB, Kwiatkowski DJ, Sahin M.

Hum Mol Genet. 2014 Jul 15;23(14):3865-74. doi: 10.1093/hmg/ddu101. Epub 2014 Mar 5.

4.

Developmental brain abnormalities in tuberous sclerosis complex: a comparative tissue analysis of cortical tubers and perituberal cortex.

Ruppe V, Dilsiz P, Reiss CS, Carlson C, Devinsky O, Zagzag D, Weiner HL, Talos DM.

Epilepsia. 2014 Apr;55(4):539-50. doi: 10.1111/epi.12545. Epub 2014 Feb 11.

5.

Developmental expression of N-methyl-D-aspartate (NMDA) receptor subunits in human white and gray matter: potential mechanism of increased vulnerability in the immature brain.

Jantzie LL, Talos DM, Jackson MC, Park HK, Graham DA, Lechpammer M, Folkerth RD, Volpe JJ, Jensen FE.

Cereb Cortex. 2015 Feb;25(2):482-95. doi: 10.1093/cercor/bht246. Epub 2013 Sep 17.

6.

Bumetanide enhances phenobarbital efficacy in a rat model of hypoxic neonatal seizures.

Cleary RT, Sun H, Huynh T, Manning SM, Li Y, Rotenberg A, Talos DM, Kahle KT, Jackson M, Rakhade SN, Berry G, Jensen FE.

PLoS One. 2013;8(3):e57148. doi: 10.1371/journal.pone.0057148. Epub 2013 Mar 11. Erratum in: PLoS One. 2013;8(8). doi:10.1371/annotation/48a011e6-e4d0-4706-9a28-857eba8cfb31. Berry, Gerard [corrected to Berry, Gerard T].

7.

Antiepileptic effects of levetiracetam in a rodent neonatal seizure model.

Talos DM, Chang M, Kosaras B, Fitzgerald E, Murphy A, Folkerth RD, Jensen FE.

Pediatr Res. 2013 Jan;73(1):24-30. doi: 10.1038/pr.2012.151. Epub 2012 Nov 8.

8.

The interaction between early life epilepsy and autistic-like behavioral consequences: a role for the mammalian target of rapamycin (mTOR) pathway.

Talos DM, Sun H, Zhou X, Fitzgerald EC, Jackson MC, Klein PM, Lan VJ, Joseph A, Jensen FE.

PLoS One. 2012;7(5):e35885. doi: 10.1371/journal.pone.0035885. Epub 2012 May 2.

9.

Altered inhibition in tuberous sclerosis and type IIb cortical dysplasia.

Talos DM, Sun H, Kosaras B, Joseph A, Folkerth RD, Poduri A, Madsen JR, Black PM, Jensen FE.

Ann Neurol. 2012 Apr;71(4):539-51. doi: 10.1002/ana.22696. Epub 2012 Mar 23.

10.

Developmental regulation of group I metabotropic glutamate receptors in the premature brain and their protective role in a rodent model of periventricular leukomalacia.

Jantzie LL, Talos DM, Selip DB, An L, Jackson MC, Folkerth RD, Deng W, Jensen FE.

Neuron Glia Biol. 2010 Nov;6(4):277-88. doi: 10.1017/S1740925X11000111. Epub 2011 Dec 14.

11.

Regulable neural progenitor-specific Tsc1 loss yields giant cells with organellar dysfunction in a model of tuberous sclerosis complex.

Goto J, Talos DM, Klein P, Qin W, Chekaluk YI, Anderl S, Malinowska IA, Di Nardo A, Bronson RT, Chan JA, Vinters HV, Kernie SG, Jensen FE, Sahin M, Kwiatkowski DJ.

Proc Natl Acad Sci U S A. 2011 Nov 8;108(45):E1070-9. doi: 10.1073/pnas.1106454108. Epub 2011 Oct 24.

12.

NMDA receptor blockade with memantine attenuates white matter injury in a rat model of periventricular leukomalacia.

Manning SM, Talos DM, Zhou C, Selip DB, Park HK, Park CJ, Volpe JJ, Jensen FE.

J Neurosci. 2008 Jun 25;28(26):6670-8. doi: 10.1523/JNEUROSCI.1702-08.2008.

13.

Cell-specific alterations of glutamate receptor expression in tuberous sclerosis complex cortical tubers.

Talos DM, Kwiatkowski DJ, Cordero K, Black PM, Jensen FE.

Ann Neurol. 2008 Apr;63(4):454-65. doi: 10.1002/ana.21342.

14.

Minocycline treatment following hypoxic/ischaemic injury attenuates white matter injury in a rodent model of periventricular leucomalacia.

Lechpammer M, Manning SM, Samonte F, Nelligan J, Sabo E, Talos DM, Volpe JJ, Jensen FE.

Neuropathol Appl Neurobiol. 2008 Aug;34(4):379-93. doi: 10.1111/j.1365-2990.2007.00925.x. Epub 2008 Jan 22.

15.

A mouse model of tuberous sclerosis: neuronal loss of Tsc1 causes dysplastic and ectopic neurons, reduced myelination, seizure activity, and limited survival.

Meikle L, Talos DM, Onda H, Pollizzi K, Rotenberg A, Sahin M, Jensen FE, Kwiatkowski DJ.

J Neurosci. 2007 May 23;27(21):5546-58.

18.

NKCC1 transporter facilitates seizures in the developing brain.

Dzhala VI, Talos DM, Sdrulla DA, Brumback AC, Mathews GC, Benke TA, Delpire E, Jensen FE, Staley KJ.

Nat Med. 2005 Nov;11(11):1205-13. Epub 2005 Oct 9.

PMID:
16227993
19.

Glutamate receptor-mediated oligodendrocyte toxicity in periventricular leukomalacia: a protective role for topiramate.

Follett PL, Deng W, Dai W, Talos DM, Massillon LJ, Rosenberg PA, Volpe JJ, Jensen FE.

J Neurosci. 2004 May 5;24(18):4412-20.

Supplemental Content

Loading ...
Support Center